Dominique M Vandijck1,2, Pieter O Depuydt3, Fritz C Offner4, Joke Nollet3, Renaat A Peleman5, Eva Steel4, Lucien A Noens4, Johan M Decruyenaere3, Dominique D Benoit3. 1. Department of Public Health and Health Economics, Faculty of Medicine and Health Sciences, Ghent University, De Pintelaan 185, 9000, Ghent, Belgium. Dominique.Vandijck@UGent.be. 2. Department of General Internal Medicine and Infectious Diseases, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. Dominique.Vandijck@UGent.be. 3. Department of Intensive Care Medicine, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. 4. Department of Hematology, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium. 5. Department of General Internal Medicine and Infectious Diseases, Ghent University Hospital, De Pintelaan 185, 9000, Ghent, Belgium.
Abstract
PURPOSE: To compare evolution in organ dysfunction (OD) between hematologic malignancy patients with and without bacterial infection (BI) precipitating intensive care unit (ICU) admission, and to assess its impact on mortality. METHODS: Retrospective analysis of prospectively collected data was performed. Sequential Organ Failure Assessment (SOFA) scores from day 1 to 5 were calculated in all consecutive hematologic malignancy patients admitted to the ICU (2000-2006). Patients were categorized according to the presence or absence, the diagnostic certainty, and the site of BI. RESULTS: Of the 344 patients admitted, 258 were still in the ICU at day 3 and 164 at day 5. Patients admitted because of BI had more severe OD on day 1 (SOFA 9.7 ± 4.0 vs. 8.4 ± 4.0, p = 0.008) but a more rapidly reversible OD within the first 3 days (ΔSOFA -1.12 ± 3.10 vs. 0.03 ± 3.40, p = 0.013) and a lower in-hospital (43.2% vs. 62.9%, p < 0.001) and 6-month mortality (52.1% vs. 71.7%, p < 0.001) than patients with other complications. In a multivariate analysis, BI remained associated with a lower risk of death (OR 0.20, 95% CI 0.1-0.4, p < 0.001) even after adjustment for the SOFA on day 1 (OR 1.36, 95% CI 1.22-1.52, p < 0.001) and the ΔSOFA (OR 1.48, 95% CI 1.29-1.68, p < 0.001). These findings remained significant regardless of the site and the diagnostic certainty of BI. CONCLUSION: BI is associated with a more severe initial but a more rapidly reversible OD and a subsequent lower mortality compared to other complications in ICU patients with hematologic malignancies. These findings further support the recommendation that these patients should certainly benefit from advanced life support, and in the case of an uncertain long-term prognosis due to the underlying malignancy, at least from a 3-day ICU trial.
PURPOSE: To compare evolution in organ dysfunction (OD) between hematologic malignancy patients with and without bacterial infection (BI) precipitating intensive care unit (ICU) admission, and to assess its impact on mortality. METHODS: Retrospective analysis of prospectively collected data was performed. Sequential Organ Failure Assessment (SOFA) scores from day 1 to 5 were calculated in all consecutive hematologic malignancy patients admitted to the ICU (2000-2006). Patients were categorized according to the presence or absence, the diagnostic certainty, and the site of BI. RESULTS: Of the 344 patients admitted, 258 were still in the ICU at day 3 and 164 at day 5. Patients admitted because of BI had more severe OD on day 1 (SOFA 9.7 ± 4.0 vs. 8.4 ± 4.0, p = 0.008) but a more rapidly reversible OD within the first 3 days (ΔSOFA -1.12 ± 3.10 vs. 0.03 ± 3.40, p = 0.013) and a lower in-hospital (43.2% vs. 62.9%, p < 0.001) and 6-month mortality (52.1% vs. 71.7%, p < 0.001) than patients with other complications. In a multivariate analysis, BI remained associated with a lower risk of death (OR 0.20, 95% CI 0.1-0.4, p < 0.001) even after adjustment for the SOFA on day 1 (OR 1.36, 95% CI 1.22-1.52, p < 0.001) and the ΔSOFA (OR 1.48, 95% CI 1.29-1.68, p < 0.001). These findings remained significant regardless of the site and the diagnostic certainty of BI. CONCLUSION: BI is associated with a more severe initial but a more rapidly reversible OD and a subsequent lower mortality compared to other complications in ICU patients with hematologic malignancies. These findings further support the recommendation that these patients should certainly benefit from advanced life support, and in the case of an uncertain long-term prognosis due to the underlying malignancy, at least from a 3-day ICU trial.
Authors: Dominique D Benoit; Pieter O Depuydt; Koenraad H Vandewoude; Fritz C Offner; Tom Boterberg; Carole A De Cock; Lucien A Noens; Ann M Janssens; Johan M Decruyenaere Journal: Intensive Care Med Date: 2005-11-25 Impact factor: 17.440
Authors: B Lamia; M-F Hellot; C Girault; F Tamion; F Dachraoui; P Lenain; G Bonmarchand Journal: Intensive Care Med Date: 2006-08-01 Impact factor: 17.440
Authors: Dominique D Benoit; Eric A Hoste; Pieter O Depuydt; Fritz C Offner; Norbert H Lameire; Koenraad H Vandewoude; Annemieke W Dhondt; Lucien A Noens; Johan M Decruyenaere Journal: Nephrol Dial Transplant Date: 2005-01-25 Impact factor: 5.992
Authors: Dominique M Vandijck; Dominique D Benoit; Pieter O Depuydt; Fritz C Offner; Stijn I Blot; Anna K Van Tilborgh; Joke Nollet; Eva Steel; Lucien A Noens; Johan M Decruyenaere Journal: Intensive Care Med Date: 2008-01-24 Impact factor: 17.440
Authors: Dominique D Benoit; Koenraad H Vandewoude; Johan M Decruyenaere; Eric A Hoste; Francis A Colardyn Journal: Crit Care Med Date: 2003-01 Impact factor: 7.598
Authors: L Platon; L Amigues; P Ceballos; N Fegueux; D Daubin; N Besnard; R Larcher; L Landreau; C Agostini; S Machado; O Jonquet; K Klouche Journal: Bone Marrow Transplant Date: 2015-11-16 Impact factor: 5.483
Authors: Jae-Uk Song; Gee Young Suh; Hye Yun Park; So Yeon Lim; Seo Goo Han; Yeh Rim Kang; O Jung Kwon; Sookyoung Woo; Kyeongman Jeon Journal: Intensive Care Med Date: 2012-05-17 Impact factor: 17.440
Authors: Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang Journal: Intensive Care Med Date: 2011-01-12 Impact factor: 17.440